<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
  <dc:creator>Anker, Daniela</dc:creator>
  <dc:creator>Santos-Eggimann, Brigitte</dc:creator>
  <dc:creator>Zwahlen, Marcel</dc:creator>
  <dc:creator>Santschi, Valérie</dc:creator>
  <dc:creator>Rodondi, Nicolas</dc:creator>
  <dc:creator>Wolfson, Christina</dc:creator>
  <dc:creator>Chiolero, Arnaud</dc:creator>
  <dc:date>2020-04-28</dc:date>
  <dc:description xmlns:ns0="xml" ns0:lang="en">The American College of Cardiology and the American Heart Association (ACC/AHA)  2017 guidelines for hypertension management lowered blood pressure (BP)  thresholds to 130/80 mmHg to define hypertension while the European Society of  Cardiology and the European Society of Hypertension (ESC/ESH) 2018 guidelines  retained 140/90 mmHg. Both guidelines recommend adapting management for older  patients with complex health conditions, without however clear indications on how to  adapt. Our aims were to assess the impact of lowering BP thresholds on the  prevalence of elevated BP and BP control, as well as the proportion of participants  with a complex health condition across these BP categories. We used data from 3210  participants in the Lausanne cohort Lc65+ aged between 67 and 80 years.  Hypertension diagnosis and antihypertensive medication use were self-reported. BP  was measured three times at one visit. Some 51% of participants reported having  hypertension and 44% reported taking antihypertensive medication. Compared with  ESC/ESH thresholds, the prevalence of measured elevated BP was 24% percentage  points higher and BP control was 24% percentage points lower using ACC/AHA  thresholds. About one out of two participants with elevated BP and four out of five  participants with uncontrolled BP had a complex health condition, i.e., frailty,  multimorbidity, or polypharmacy. To comply with ACC/AHA guidelines, considerable  effort would be required to reach BP control. This is a serious challenge because a  large share of hypertensive older adults has complex health conditions, a type of  patients for whom there is no strong evidence on how to manage hypertension.</dc:description>
  <dc:format>application/pdf</dc:format>
  <dc:identifier>https://folia.unifr.ch/global/documents/309340</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/309340/files/chi_bpc.pdf</dc:identifier>
  <dc:identifier>https://folia.unifr.ch/documents/309340/files/chi_bpc_sm.pdf</dc:identifier>
  <dc:language>eng</dc:language>
  <dc:relation>info:eu-repo/semantics/altIdentifier/doi/10.1038/s41371-020-0334-4</dc:relation>
  <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
  <dc:rights>License undefined</dc:rights>
  <dc:source>Journal of Human Hypertension. - 2021, vol. 35, no. 3, p. 280-289</dc:source>
  <dc:subject>info:eu-repo/classification/udc/61</dc:subject>
  <dc:title xmlns:ns1="xml" ns1:lang="en">Blood pressure control and complex health conditions in older adults: impact of recent hypertension management guidelines</dc:title>
  <dc:type>http://purl.org/coar/resource_type/c_6501</dc:type>
</oai_dc:dc>
